Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Guardant Health, Inc. filed this Current Report on Form 8-K on November 6, 2023, to announce financial results for the fiscal quarter ended September 30, 2023. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "GH."
Key Financial Metrics
This filing serves as a notification of the release of financial results and incorporates the press release as Exhibit 99.1. The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release (Exhibit 99.1) for detailed financial data.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. Such information is contained within the referenced press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the body of this Form 8-K. The filing explicitly states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 6, 2023) for actual revenue, net loss, and cash position figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the press release.
- Check for any updated forward-looking guidance or operational milestones announced in the press release.
- Confirm the status of the Company's liquidity and capital resources as detailed in the full financial disclosure.